<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
hero-press-releases-1

Newsroom

Press Releases

Our latest announcements

Posts in: Veristrat

Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic Test

A recent study published in the peer-reviewed journal Managed Care affirms VeriStrat; demonstrates the value of the VeriStrat lung cancer test

Interim Results from Biodesix® Study Indicate That VeriStrat Testing Impacts Treatment Decisions Across All Stages of Non-Small Cell Lung Cancer

Interim study results: Veristrat testing impacts lung cancer treatment in all stages; early stage patients get significantly different treatments after test

Biodesix® and Positive Bioscience Announce Partnership to Bring Cancer Tests to India

The Positive Bioscience agreement will make GeneStrat and VeriStrat tests available in India

New Study Shows Advanced Diagnostic Tests, Including the VeriStrat® Test, Can Help Physicians Improve Cancer Care Planning and Reach Quality Measures For Patients

A new study demonstrates that VeriStrat can help physicians improve quality care and cancer care planning for patients with advanced lung cancer.

New Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer Patients

VeriStrat test saved an average of $1,050 per patient while improving survival outcomes (as compared to patients treated without the use of the test).

Biodesix® and Progenetics Announce Distribution Agreement for Israel

Biodesix and Progenetics have entered into an international agreement; Biodesix tests will be available in Israel for the first time.

Clin-TOF Successfully Integrated into VeriStrat® Workflow

Clin-TOF successfully integrated into VeriStrat® workflow

Biodesix® and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat® Test in Greater China

Biodesix and Bioyong announced a $38M deal for development and commercialization of VeriStrat in China.

200 Million Americans Now Have Insurance Coverage for Biodesix’ VeriStrat Test

With positive coverage decisions from BCBS Florida and HCSC, 200 million Americans now have insurance coverage for VeriStrat testing.

VeriStrat and Epidermal Growth Factor Receptor Mutation Status Study Results Presented at 16th World Conference On Lung Cancer

VeriStrat and Epidermal Growth Factor Receptor Mutation Status Study results presented at 16th World Conference on Lung Cancer

1 2 3 4 5 6 Last